DNTT and B-cell non-Hodgkin lymphoma: Designating these cases as DHL/THL and qualifying with TdT expression (e.g., “High grade B-cell lymphoma with MYC and BCL2 rearrangements, and expression of TdT”) is preferred by the panel [46].